Señales en vivo de FAB.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 04:29):
Our systems believe the stock currently is undervalued by 0.00% compare to its pairs and should correct upwards.

Stats
Volumen de hoy	25 193
Volumen promedio	946 307
Capitalización de mercado	2.96M
EPS	£-0.0292 ( Q2 \| 2023-09-30 )
Próxima fecha de ganancias	( £0 ) 2024-09-27
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.340 (Sector) 0 (Industry) 0
ATR14	£0.0830 (2.68%)

AMYT.L -11.73%

APH.L 0.28%

AVCT.L -1.69%

AZN.L -0.44%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 3.40%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.98%

FUM.L 0.27%

GDR.L 1.10%

GNS.L 1.45%

GSK.L -0.51%

HCM.L -0.36%

HEMO.L -2.66%

HIK.L -0.53%

IMM.L -1.15%

INDV.L 0.08%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.42%

NFX.L -5.00%

OBD.L 3.33%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.63%

OVB.L -2.22%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 0.98%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 7.24%

SCLP.L -1.86%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

Correlación (AI algo v.1.1b): Undervalued: 0.00% £3.10 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Fusion Antibodies PLC Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fusion Antibodies PLC Finanzas

Annual	2022
Ingresos:	£2.90M
Beneficio Bruto:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Ingresos:	£2.90M
Beneficio Bruto:	£202 000 (6.96 %)
EPS:	£-0.0998

FY	2022
Ingresos:	£4.80M
Beneficio Bruto:	£2.47M (51.39 %)
EPS:	£-0.0463

FY	2021
Ingresos:	£4.17M
Beneficio Bruto:	£2.02M (48.60 %)
EPS:	£-0.131

Financial Reports:

No articles found.

Fusion Antibodies PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fusion Antibodies PLC

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.